Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities in 2021.

  • Authors : Vidyasagar N; Pritzker School of Medicine, The University of Chicago, Chicago, Illinois.; Bunting SR

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/administration & dosage ; Buprenorphine*/Buprenorphine*/Buprenorphine*/supply & distribution ; Buprenorphine*/Buprenorphine*/Buprenorphine*/therapeutic use

  • Source: JAMA [JAMA] 2024 Feb 13; Vol. 331 (6), pp. 524-526.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder.

  • Authors : Foot C; Department of Medicine, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR, USA.; Korthuis PT

Subjects: Central Nervous System Stimulants*/Central Nervous System Stimulants*/Central Nervous System Stimulants*/adverse effects ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/epidemiology

  • Source: Addiction (Abingdon, England) [Addiction] 2024 Jan; Vol. 119 (1), pp. 149-157. Date of Electronic Publication: 2023 Sep 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs.

  • Authors : Mariani JJ; Division on Substance Use Disorders, New York State Psychiatric Institute, New York, New York, USA.; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York, USA.

Subjects: Buprenorphine* ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy; Humans

  • Source: The American journal on addictions [Am J Addict] 2024 Jan; Vol. 33 (1), pp. 8-14. Date of Electronic Publication: 2023 Nov 08.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9208821 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Retrospective analysis of the biopharmaceutics characteristics of solid oral Modified-Release drug products in approved US FDA NDAs designated as Extended-Release or Delayed-Release formulations.

  • Authors : Ahmed N; U.S. Food and Drug Administration (FDA), United States. Electronic address: .; Ly H

Subjects: Biopharmaceutics* ; Polymers*; United States

  • Source: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2023 Dec; Vol. 193, pp. Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Racial disparities in utilization of first-generation versus second-generation long-acting injectable antipsychotics in Medicaid beneficiaries with schizophrenia.

  • Authors : Pesa J; Janssen Scientific Affairs, LLC, Titusville, NJ, USA. Electronic address: .; Liu Z

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy; Adult

  • Source: Schizophrenia research [Schizophr Res] 2023 Nov; Vol. 261, pp. 170-177. Date of Electronic Publication: 2023 Sep 29.Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Use and Cost of Sustained-Release Corticosteroids for Cataract Surgery Under the Medicare Pass-Through Program.

  • Authors : Dai X; The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Chang DF

Subjects: Cataract Extraction*/Cataract Extraction*/Cataract Extraction*/economics ; Cataract*; Aged

  • Source: JAMA ophthalmology [JAMA Ophthalmol] 2023 Sep 01; Vol. 141 (9), pp. 844-851.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print

Record details

×
Academic Journal

Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stay.

  • Authors : Patel C; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.; Pilon D

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy; Adult

  • Source: Current medical research and opinion [Curr Med Res Opin] 2023 Aug; Vol. 39 (8), pp. 1157-1166. Date of Electronic Publication: 2023 Jul 28.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients.

  • Authors : Childress A; Center for Psychiatry and Behavioral Medicine, Inc, Las Vegas, NV, USA.; Sottile R

Subjects: Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/drug therapy ; Viloxazine*/Viloxazine*/Viloxazine*/therapeutic use ; Methylphenidate*/Methylphenidate*/Methylphenidate*/therapeutic use

  • Source: Expert review of neurotherapeutics [Expert Rev Neurother] 2023 Jul-Dec; Vol. 23 (11), pp. 945-953. Date of Electronic Publication: 2023 Oct 27.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101129944 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Studying Drug Release through Polymeric Controlled Release Formulations in United States Pharmacopoeia 2 Apparatus Using Multiphysics Simulation and Experiments.

  • Authors : Ranjan A; Department of Chemical Engineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand 247667, India.; Jha PK

Subjects: Computer Simulation* ; Delayed-Action Preparations* ; Drug Liberation*

  • Source: Molecular pharmaceutics [Mol Pharm] 2021 Jul 05; Vol. 18 (7), pp. 2600-2611. Date of Electronic Publication: 2021 May 30.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic

Record details

×
Academic Journal

Current and future directions of drug delivery for the treatment of mental illnesses.

  • Authors : Brewster PR; Department of Biomedical Engineering, University of Mississippi, University, MS 38677, USA; Department of Chemical Engineering, University of Mississippi, University, MS 38677, USA.

Subjects: Autism Spectrum Disorder* ; Mental Disorders*/Mental Disorders*/Mental Disorders*/drug therapy ; Pharmacy*

  • Source: Advanced drug delivery reviews [Adv Drug Deliv Rev] 2023 Jun; Vol. 197, pp. 114824. Date of Electronic Publication: 2023 Apr 15.Publisher: Elsevier Science Publishers, B.V Country of Publication: Netherlands NLM ID: 8710523 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Long-Acting Injectable Clozapine Not Available in the United States.

Subjects: Clozapine* ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use; Humans

  • Source: American family physician [Am Fam Physician] 2023 Jun; Vol. 107 (6), pp. 568.Publisher: American Academy of General Practice Country of Publication: United States NLM ID: 1272646 Publication Model: Print

Record details

×
Academic Journal

Treatment Journey From Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia.

  • Authors : Kane JM; The Zucker Hillside Hospital, Northwell Health, Department of Psychiatry, Glen Oaks, New York.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnosis ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

  • Source: The Journal of clinical psychiatry [J Clin Psychiatry] 2023 Apr 19; Vol. 84 (3). Date of Electronic Publication: 2023 Apr 19.Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 7801243 Publication Model: Electronic

Record details

×
Academic Journal

Association of T-wave abnormalities with major cardiovascular events in diabetes: the ACCORD trial.

  • Authors : Mould SJ; Section of Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.; Soliman EZ

Subjects: Action Potentials* ; Electrocardiography* ; Heart Rate*

  • Source: Diabetologia [Diabetologia] 2021 Mar; Vol. 64 (3), pp. 504-511. Date of Electronic Publication: 2021 Jan 08.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Environmental Decision-Making in Times of Polarization.

Subjects: Decision making; Polarization (Social sciences); Collective actionUnited States

  • Source: Annual Review of Environment & Resources. Nov2023, Vol. 48, p477-503. 27p.

Record details

×
Academic Journal

How Hazardous Is Your State to Your Health?

Subjects: Public Health; Death; Mortality RateUnited States

  • Source: American Journal of Health Education. 2024 55(1):1-13.13

Record details

×
Academic Journal

Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia.

  • Authors : Rubio JM; The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy; Aged

  • Source: The Journal of clinical psychiatry [J Clin Psychiatry] 2023 Feb 13; Vol. 84 (2). Date of Electronic Publication: 2023 Feb 13.Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 7801243 Publication Model: Electronic

Record details

×
Academic Journal

Does XR injectable naltrexone prevent relapse as effectively as daily sublingual buprenorphine-naloxone?

  • Authors : Roe M; Mountain Area Health Education Center (MAHEC), Asheville, NC, USA.; Wilson CG

Subjects: Administration, Sublingual* ; Injections, Intramuscular*; Buprenorphine, Naloxone Drug Combination/Buprenorphine, Naloxone Drug Combination/Buprenorphine, Naloxone Drug Combination/*administration & dosage

  • Source: The Journal of family practice [J Fam Pract] 2020 Dec; Vol. 69 (10), pp. E14-E15.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print

Record details

×
Academic Journal

Application of Clinical Pharmacology Principles in Drug Development of Modified-Release Products: Leveraging Exposure-Response Information to Support Approval.

  • Authors : AbuAsal BS; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Hamed SS

Subjects: Drug Development*; Delayed-Action Preparations/Delayed-Action Preparations/Delayed-Action Preparations/*pharmacokinetics ; Drug Approval/Drug Approval/Drug Approval/*methods

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2020 Nov; Vol. 60 (11), pp. 1441-1452. Date of Electronic Publication: 2020 May 26.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

×
Academic Journal

Barriers to Long-acting Injectable Antipsychotic Adherence During the COVID-19 Pandemic: Observations From One Site.

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; COVID-19* ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

  • Source: Journal of psychiatric practice [J Psychiatr Pract] 2022 Nov 01; Vol. 28 (6), pp. 497-504. Date of Electronic Publication: 2022 Nov 01.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100901141 Publication Model: Electronic

Record details

×
Academic Journal

Clinical and economic impact of long-acting injectable antipsychotics in patients previously treated with short-acting oral antipsychotics.

  • Authors : Kheloussi S; Department of Pharmacy Practice, Nesbitt School of Pharmacy, Wilkes University, Wilkes-Barre, PA.; Oberlin J Jr

Subjects: Antipsychotic Agents* ; Schizophrenia*; Aged

  • Source: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2022 Oct; Vol. 28 (10), pp. 1130-1137.Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print

Record details

×
Academic Journal

Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) study.

  • Authors : Basu A; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle.; Salutis Consulting LLC, Bellevue, WA.

Subjects: Antipsychotic Agents*; Administration, Oral ; Adult

  • Source: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2022 Oct; Vol. 28 (10), pp. 1086-1095.Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print

Record details

×
Academic Journal

Regulatory aspects and quality controls of polymer-based parenteral long-acting drug products: the challenge of approving copies.

  • Authors : Selmin F; Department of Pharmaceutical Sciences, Università degli Studi di Milano, Via G. Colombo, 71, 20133 Milan, Italy.; Musazzi UM

Subjects: Delayed-Action Preparations* ; Drug Approval* ; Drugs, Generic*

  • Source: Drug discovery today [Drug Discov Today] 2020 Feb; Vol. 25 (2), pp. 321-329. Date of Electronic Publication: 2019 Dec 26.Publisher: Elsevier Science Ltd. Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Modeling operational quality metrics and costs of long-acting antibiotics for acute bacterial skin and skin structure infection treatment in the emergency department.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*economics ; Delayed-Action Preparations/Delayed-Action Preparations/Delayed-Action Preparations/*economics ; Emergency Service, Hospital/Emergency Service, Hospital/Emergency Service, Hospital/*economics

  • Source: Journal of medical economics [J Med Econ] 2019 Jul; Vol. 22 (7), pp. 652-661. Date of Electronic Publication: 2019 Apr 02.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia.

  • Authors : Tidmore LM; Department of Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA.; Keast SL

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Bipolar Disorder*/Bipolar Disorder*/Bipolar Disorder*/drug therapy ; Schizophrenia*

  • Source: Current medical research and opinion [Curr Med Res Opin] 2022 Sep; Vol. 38 (9), pp. 1621-1630. Date of Electronic Publication: 2022 Aug 01.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Sustained drug delivery strategies for treatment of common substance use disorders: Promises and challenges.

  • Authors : Tijani AO; Department of Pharmaceutical Sciences, Bill Gatton College of Pharmacy, East Tennessee State University, Johnson City, TN 37614, USA. Electronic address: .; Garg J

Subjects: Alcoholism*/Alcoholism*/Alcoholism*/drug therapy ; Alcoholism*/Alcoholism*/Alcoholism*/epidemiology ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy

  • Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2022 Aug; Vol. 348, pp. 970-1003. Date of Electronic Publication: 2022 Jul Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Periodical

Postal piety.

Subjects: *ACTIONS & defenses (Law); APPELLATE courts; FREEDOM of religionUNITED States

  • Source: Economist. 4/22/2023, Vol. 447 Issue 9343, p24-25. 2p.

Record details

×
Periodical

Rulings have consequences.

Subjects: *ACTIONS & defenses (Law); WOMEN'S rights; ABORTIONUNITED States

  • Source: Economist. 4/22/2023, Vol. 447 Issue 9343, p20-22. 2p.

Record details

×
Periodical

Sue the Left.

Subjects: *ACTIONS & defenses (Law); CONSERVATISM; RACIAL inequalityUNITED StatesMILLER, Stephen, 1985-; TRUMP, Donald, 1946-

  • Source: Bloomberg Businessweek. 10/18/2021, Issue 4717, p42-43. 2p. 1 Color Photograph.

Record details

×
Academic Journal

Evaluating the pharmacokinetics of extended release viloxazine in the treatment of children with attention-deficit/hyperactivity disorder.

  • Authors : Childress A; Center for Psychiatry and Behavioral Medicine, Inc, Las Vegas, Nevada, USA.; Burton S

Subjects: Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/drug therapy ; Central Nervous System Stimulants* ; Viloxazine*/Viloxazine*/Viloxazine*/therapeutic use

  • Source: Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2022 Jun; Vol. 18 (6), pp. 357-366. Date of Electronic Publication: 2022 Jul 25.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee.

  • Authors : Paik J; Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. .; Duggan ST

Subjects: Delayed-Action Preparations/Delayed-Action Preparations/Delayed-Action Preparations/*therapeutic use ; Osteoarthritis, Knee/Osteoarthritis, Knee/Osteoarthritis, Knee/*drug therapy ; Pain/Pain/Pain/*drug therapy

  • Source: Drugs [Drugs] 2019 Mar; Vol. 79 (4), pp. 455-462.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Interest of Youth Living With HIV in Long-Acting Antiretrovirals.

  • Authors : Weld ED; Divisions of Clinical Pharmacology and Infectious Diseases, Johns Hopkins University, Baltimore, MD.; Rana MS

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Delayed-Action Preparations/Delayed-Action Preparations/Delayed-Action Preparations/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2019 Feb 01; Vol. 80 (2), pp. 190-197.Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print

Record details

×
Academic Journal

Novel Method for Assessment of His Bundle Pacing Morphology Using Near Field and Far Field Device Electrograms.

  • Authors : Saini A; Division of Cardiac Electrophysiology, Virginia Commonwealth University Pauley Heart Center, Richmond (A.S., J.K., G.K., S.K.P., R.K.S., J.N.K., K.A.E.).; Serafini NJ

Subjects: Action Potentials* ; Electrophysiologic Techniques, Cardiac*; Arrhythmias, Cardiac/Arrhythmias, Cardiac/Arrhythmias, Cardiac/*therapy

  • Source: Circulation. Arrhythmia and electrophysiology [Circ Arrhythm Electrophysiol] 2019 Feb; Vol. 12 (2), pp. e006878.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101474365 Publication Model: Print

Record details

×
  • 1-50 of  435,918 results for ""ACTIONS "